Safety and Tolerability Profile of Rifaximin for Treatment of IBS Without Constipation: Results of a Pooled Analysis of Double-Blind, Placebo-Controlled Randomized Controlled Trials

被引：0
|
作者：
Chang, Lin
Chey, William D.
Drossman, Douglas A.
Lembo, Anthony
Pimentel, Mark
Schoenfeld, Philip S.
Yu, Jing
Merchant, Kunal
Paterson, Craig
Bortey, Enoch
Forbes, William P.
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S823 / S823
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials
    Schoenfeld, P.
    Pimentel, M.
    Chang, L.
    Lembo, A.
    Chey, W. D.
    Yu, J.
    Paterson, C.
    Bortey, E.
    Forbes, W. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1161 - 1168
  • [2] Safety and Tolerability of Rifaximin in the Treatment of Irritable Bowel Syndrome (IBS): A Pooled Analysis of 4 Randomized, Placebo-Controlled Trials
    Lembo, Anthony J.
    Pimentel, Mark
    Wolf, Ray
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
  • [3] A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia
    Geisser, Michael E.
    Palmer, Robert H.
    Gendreau, R. Michael
    Wang, Yong
    Clauw, Daniel J.
    [J]. PAIN PRACTICE, 2011, 11 (02) : 120 - 131
  • [4] Cardiovascular safety of eptinezumab: A pooled analysis of double-blind, randomized, placebo-controlled studies
    Smith, T. R.
    Spierings, E. L. H.
    Cady, R.
    Hirman, J.
    Ettrup, A.
    Shen, V
    [J]. HEADACHE, 2021, 61 : 112 - 112
  • [5] Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
    Dao Thai-Cuarto
    Christopher F. O’Brien
    Roland Jimenez
    Grace S. Liang
    Joshua Burke
    [J]. Drug Safety, 2018, 41 : 429 - 440
  • [6] Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
    Dao Thai-Cuarto
    O'Brien, Christopher F.
    Jimenez, Roland
    Liang, Grace S.
    Burke, Joshua
    [J]. DRUG SAFETY, 2018, 41 (04) : 429 - 440
  • [7] Rifaximin for the treatment of functional dyspepsia: a double-blind randomized placebo-controlled trial
    Tan, V.
    Liu, K.
    Lam, F.
    Hung, I.
    Yuen, M.
    Leung, W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 154 - 154
  • [8] Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study
    Kienzle-Horn, S
    Vix, JM
    Schuijt, C
    Peil, H
    Jordan, CC
    Kamm, MA
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (10) : 1479 - 1488
  • [9] Safety and Tolerability of Dexpramipexole for the Treatment of ALS: Results from the Randomized, Double-Blind, Placebo-Controlled Trial, EMPOWER
    Van den Berg, Leonard
    Cudkowicz, Merit
    Shefner, Jeremy
    Mitsumoto, Hiroshi
    Mora, Jesus
    Ludolph, Albert
    Hardiman, Orla
    Ingersoll, Evan
    Archibald, Donald
    Li, Xiaoxi
    Dong, Yingwen
    Kerr, Douglas
    Farwell, Wildon
    [J]. NEUROLOGY, 2013, 80
  • [10] THE SAFETY AND TOLERABILITY OF LACOSAMIDE IN RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II/III CLINICAL TRIALS
    Gil-Nagel, A.
    Biton, V.
    Fountain, N.
    Rosenow, F.
    Hebert, D.
    Doty, P.
    [J]. EPILEPSIA, 2009, 50 : 110 - 110
12345